ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2,1,Headache,Headaches NEC,Headaches,Nerv,N
2,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2,3,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
3,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
4,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
4,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5,1,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
6,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
7,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
7,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
8,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
9,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
9,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
10,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
10,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
10,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11,2,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
11,3,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
12,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
13,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
13,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
14,1,Enzyme induction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
14,2,International normalised ratio decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
15,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
16,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
16,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
16,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
17,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
17,2,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
17,3,Headache,Headaches NEC,Headaches,Nerv,N
17,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
17,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
17,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
17,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
18,1,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
18,2,Oligomenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
19,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
19,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
19,3,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
20,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
20,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
20,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
21,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
21,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
22,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
22,2,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
22,3,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
22,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
23,1,International normalised ratio decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
